2.42 0.03 (1.26%)

44.24% Fall from 52W High

3.0M XNAS Volume

XNAS 17 Apr, 2025 5:30 PM (EDT)

AbCellera Biologics Inc - ABCL - stock price prediction, stock price target, analyst ratings from 9 analysts

AbCellera Biologics Inc has a share price target of US$ 12, revenue growth forecast of -7.0%, and profit growth estimate of -19.5% for FY25, based on top 9 analyst calls.